Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 34.2B | 33.0B | 33.0B | 31.9B |
Cost of revenue | 21.4B | 20.8B | 20.7B | 19.4B |
Gross profit | 12.8B | 12.2B | 12.4B | 12.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 6.7B | 6.6B | 6.6B | 6.7B |
Operating income | 2.4B | 2.0B | 2.3B | 2.5B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 744M | 750.9M | 664.5M | 618.5M |
Other income expense | — | — | — | — |
Pretax income | 1.3B | 1.3B | 1.6B | 2.0B |
Tax provision | 356M | 361.4M | 463.1M | 539.8M |
Net income | 987.1M | 970.3M | 1.2B | 1.5B |
Basic EPS | — | 24.0 | 30.1 | 38.1 |
Diluted EPS | — | 24.0 | 30.1 | 38.1 |
Basic average shares | — | 40.4M | 40.5M | 40.5M |
Diluted average shares | — | 40.4M | 40.5M | 40.5M |
EBITDA | 3.9B | 3.4B | 3.7B | 3.9B |
Net income from continuing op. | — | — | — | — |
Minority interests | 7.8M | 800K | 4.3M | -200K |
Preferred stock dividends | 0 | 0 | 0 | 0 |